Biomarkers in the Management and Treatment of Men with Metastatic Castration-Resistant Prostate Cancer

CONTEXT: We have recently witnessed a rapid increase in the number of effective systemic agents for men with metastatic castration-resistant prostate cancer (CRPC), including novel hormonal therapies (abiraterone acetate and MDV3100), immunotherapies (sipu-leucel-T), chemotherapies (cabazitaxel), an...

Full description

Saved in:
Bibliographic Details
Main Authors: Armstrong, Andrew J., Eisenberger, Mario A., Halabi, Susan, Oudard, Stephane, Nanus, David M., Petrylak, Daniel P., Sartor, A. Oliver, Scher, Howard I.
Format: Artigo
Language:Inglês
Published: 2011
Subjects:
Article
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC3445625/
https://ncbi.nlm.nih.gov/pubmed/22099611
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.eururo.2011.11.009
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items